Correlation Between Porsche Automobil and CRISPR Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Porsche Automobil and CRISPR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Porsche Automobil and CRISPR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Porsche Automobil Hg and CRISPR Therapeutics AG, you can compare the effects of market volatilities on Porsche Automobil and CRISPR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Porsche Automobil with a short position of CRISPR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Porsche Automobil and CRISPR Therapeutics.

Diversification Opportunities for Porsche Automobil and CRISPR Therapeutics

0.74
  Correlation Coefficient

Poor diversification

The 3 months correlation between Porsche and CRISPR is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Porsche Automobil Hg and CRISPR Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CRISPR Therapeutics and Porsche Automobil is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Porsche Automobil Hg are associated (or correlated) with CRISPR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CRISPR Therapeutics has no effect on the direction of Porsche Automobil i.e., Porsche Automobil and CRISPR Therapeutics go up and down completely randomly.

Pair Corralation between Porsche Automobil and CRISPR Therapeutics

Assuming the 90 days horizon Porsche Automobil Hg is expected to generate 0.68 times more return on investment than CRISPR Therapeutics. However, Porsche Automobil Hg is 1.47 times less risky than CRISPR Therapeutics. It trades about 0.0 of its potential returns per unit of risk. CRISPR Therapeutics AG is currently generating about -0.04 per unit of risk. If you would invest  6,890  in Porsche Automobil Hg on August 29, 2022 and sell it today you would lose (829.00)  from holding Porsche Automobil Hg or give up 12.03% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Porsche Automobil Hg  vs.  CRISPR Therapeutics AG

 Performance (%) 
       Timeline  
Porsche Automobil 
Porsche Performance
0 of 100
Over the last 90 days Porsche Automobil Hg has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical indicators remain rather sound which may send shares a bit higher in December 2022. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Porsche Price Channel

CRISPR Therapeutics 
CRISPR Performance
0 of 100
Over the last 90 days CRISPR Therapeutics AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2022. The recent disarray may also be a sign of long period up-swing for the firm insiders.

CRISPR Price Channel

Porsche Automobil and CRISPR Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Porsche Automobil and CRISPR Therapeutics

The main advantage of trading using opposite Porsche Automobil and CRISPR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Porsche Automobil position performs unexpectedly, CRISPR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CRISPR Therapeutics will offset losses from the drop in CRISPR Therapeutics' long position.
Porsche Automobil vs. RLX Technology
The idea behind Porsche Automobil Hg and CRISPR Therapeutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
CRISPR Therapeutics vs. Regeneron Pharmaceuticals
CRISPR Therapeutics vs. Vertex Pharmaceutic
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go